New guidelines on hypertension

Lancet

Volumn 368, Issue 9536, 2006, Pages 641-

  Cruickshank, JM ^a  

^a NONE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; AMLODIPINE; BENDROFLUMETHIAZIDE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CALCIUM ANTAGONIST; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOXAZOSIN; GLYCOSYLATED HEMOGLOBIN; LISINOPRIL; CALCIUM CHANNEL BLOCKING AGENT;

AGING; ARTERY COMPLIANCE; BETA ADRENERGIC RECEPTOR BLOCKING; CLINICAL TRIAL; DISEASE ASSOCIATION; ENZYME INHIBITION; FOLLOW UP; HEALTH CARE ORGANIZATION; HUMAN; HYPERTENSION; LETTER; OBESITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; SYSTOLIC HYPERTENSION; VASCULAR RESISTANCE; ADULT; AGE; AGED; MIDDLE AGED; NOTE;

ADRENERGIC BETA-ANTAGONISTS; ADULT; AGE FACTORS; AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; HUMANS; HYPERTENSION; MIDDLE AGED;

EID: 33747367731     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(06)69233-7     Document Type: Letter

References (5)

1. Williams B. Evolution of hypertensive disease: a revolution in guidelines. Lancet 368 (2006) 6-8
2. Deary A., Schulman A., Murfet H., Haydock S., Foo R.-Y., and Brown M. Double-blind, placebo-controlled cross-over comparison of 5 classes of antihypertensive drugs. J Hypertens 20 (2002) 771-777
3. UK Prospective Study Group. Efficacy of atenolol and captopril in reducing the risk of macrovascular and microvascular complication in type 2 diabetes. BMJ 317 (1998) 713-720
4. Franklin S., Pio J., Wong N., Larson M., Leip E., and Vasan R. Predictors of new-onset diastolic and systolic hypertension. Circulation 111 (2005) 1121-1127
5. Schlaich M., Lambert E., Kaye D., et al. Sympathetic augmentation in hypertension. Hypertension 43 (2004) 169-175